Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SPECT/CT Prospective Double-Scanning Study

NCT: NCT07725237 · NOT_YET_RECRUITING

NCT IDNCT07725237
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-02
SponsorGE Healthcare (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this study is to collect image data for StarGuide GX SPECT/CT System in a clinical setting. The StarGuide GX scan will be compared to the participant's clinically indicated SPECT/CT scanner. Participants will be adult patients scheduled to undergo a clinically indicated SPECT/CT.

Frequently Asked Questions

What is SPECT/CT Prospective Double-Scanning Study?

SPECT/CT Prospective Double-Scanning Study is a clinical trial registered under NCT07725237. Current status: NOT_YET_RECRUITING.

What is the status of NCT07725237?

The current status of NCT07725237 (SPECT/CT Prospective Double-Scanning Study) is: NOT_YET_RECRUITING.

When did SPECT/CT Prospective Double-Scanning Study start?

SPECT/CT Prospective Double-Scanning Study started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.